文献速递外周动脉疾病

锯齿状血管成形术治疗慢性肢体威胁性缺血的足部动脉病变:技术成功与临床结局

Technical Success and Clinical Outcomes of Pedal Serration Angioplasty for Chronic Limb-Threatening Ischemia.
PubMed 文献 · J Endovasc Ther · 2026-04-20

这项多中心回顾性研究纳入45例因慢性肢体威胁性缺血(CLTI)接受足部(踝下)血管锯齿状血管成形术(SA)的患者,主要终点技术成功(残余狭窄<50%)达93.3%,血管损伤发生率低,中位随访163天时伤口愈合率为48.7%,愈合或改善合计79.5%。

要点

  • 足部SA技术成功率高(残余狭窄<50%者93.3%),血管损伤发生率低。
  • 6个月免于大截肢率、免于足部临床驱动靶病变血运重建率均为93.3%。
  • 中位随访163天,伤口完全愈合率48.7%,愈合或改善合计79.5%。

核心结论

  • 对CLTI患者的踝下血管行锯齿状血管成形术技术成功率高、血管损伤发生率低。
  • 中位随访5.4个月时,伤口愈合情况优于既往已发表的踝下介入研究。

研究设计与样本

  • 多中心回顾性研究,纳入2021年1月1日至2023年3月31日因CLTI接受足部血管SA的患者45例。
  • 足部血管定义为踝关节(距小腿关节)以远的任何踝下血管。
  • 收集患者人口学、解剖与技术细节、急性手术结局及最近随访结局进行分析。
  • 主要终点为技术成功,定义为SA后靶血管残余狭窄<50%。

主要发现

  • 干预前Rutherford分级中位数为5,91.9%的患者合并膝下胫动脉介入。
  • 最常治疗的动脉为足背动脉(59.2%),SA中位直径为2.5 mm。
  • 残余狭窄<50%者占93.3%,<30%者占82.2%。
  • 免于血管损伤率为93.3%(1例即刻闭塞、2例补救性支架)。
  • 6个月免于大截肢率93.3%、免于足部CD-TLR率93.3%、免于MALE率80.0%。

临床怎么用

  • 对于CLTI合并足部动脉闭塞性病变的患者,可考虑采用锯齿状血管成形术实现管腔获得。
  • 该技术围术期血管损伤风险低,但需注意少数病例可能需要补救性支架。

局限性

  • 本研究为多中心回顾性研究,样本量45例,随访时间较短(中位163天)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Patients with pedal artery occlusive disease have limited options when presenting with chronic limb-threatening ischemia (CLTI). Serration angioplasty (SA) has demonstrated less recoil and improved freedom from reintervention compared with plain old balloon angioplasty within the tibial vessels. We aimed to identify the technical feasibility and clinical outcomes of SA within the pedal (inframalleolar) vasculature in patients with CLTI. MATERIALS AND METHODS: Patient with SA of the pedal vasculature for CLTI from January 01, 2021 to March 31, 2023 were included in this multicenter retrospective study. Pedal vessels were defined as any inframalleolar vessel distal to the talocrural joint. Patient demographics, anatomic and technical details, acute procedural outcomes, and outcomes at the most recent follow-up were collected for analysis. The primary endpoint was technical success, defined as SA with <50% residual target vessel stenosis. Secondary endpoints included freedom from vessel injury, amputation-free survival, clinically-driven target lesion revascularization (CD-TLR), composite major adverse limb events (MALEs), wound healing rate, and improvement in wound, ischemia, and foot infection (WIfI) clinical stage at the most recent follow-up. RESULTS: Of the identified 45 patients managed with pedal SA, median pre-intervention Rutherford classification was 5, and 91.9% of patients had concomitant below-the-knee tibial artery intervention. The most commonly treated artery was the dorsalis pedis (59.2%), with a median diameter SA of 2.5 mm. Residual stenosis was <50% in 93.3% of cases and <30% in 82.2%. Freedom from vessel injury was 93.3% (1 immediate occlusion and 2 bail-out stents). Six-month freedom from major amputation was 93.3%, freedom from pedal CD-TLR was 93.3%, and freedom from MALE was 80.0%. At a median follow-up of 163 days, 48.7% of patients had complete wound healing, with the total frequency of either healed or improving wounds of 79.5%. CONCLUSION: Serration angioplasty of the inframalleolar vasculature in patients with CLTI had high rates of technical success with a low incidence of vessel injury. At a median follow-up of 5.4 months, wound healing was ahead of previously published studies on inframalleolar intervention.Clinical ImpactThis represents the largest series of a specialty balloon used to treat pedal occlusive disease in chronic limb-threatening ischemia patients. As the rate of pedal intervention increases, using new technology to safely achieve luminal gain is crucial for both short- and long-term limb salvage.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Gifford E, Siah M, Lichtenberg M, et al. Technical Success and Clinical Outcomes of Pedal Serration Angioplasty for Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2026. PMID: 42003375. doi:10.1177/15266028261440736

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。